Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis
Open Access
- 1 January 2005
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 9 (6), R596-R600
- https://doi.org/10.1186/cc3808
Abstract
In acute disseminated intravascular coagulation, the effect of antithrombin (AT) administration on elevated levels of D-dimer is not well established. In the present study, we report on changes in circulating levels of D-dimer in response to administration of AT in a series of patients with acquired AT deficiency due to severe sepsis. Eight consecutive critically ill medical patients presenting with acute disseminated intravascular coagulation associated with severe sepsis/septic shock received a single bolus infusion of AT over 30 minutes, aiming to achieve physiological AT levels. Haemostatic parameters including D-dimer were assessed prior to, 6 and 24 h after AT administration. An average of 42 ± 9 U/kg body weight was infused. Following AT substitution, elevated levels of D-dimer fell whereas AT levels rose. These observations support the notion that AT can favourably affect fibrin degradation accompanying disseminated intravascular coagulation of severe sepsis.Keywords
This publication has 18 references indexed in Scilit:
- High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: Efficacy and safety*Critical Care Medicine, 2006
- Hemostatic markers and the sepsis‐related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unitAmerican Journal of Hematology, 2004
- Clinical Trial Design and Outcomes in Patients with Severe SepsisShock, 2003
- Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms.2002
- Fibrin Degradation Products, Fibrin Monomer and Soluble Fibrin in Disseminated Intravascular CoagulationSeminars in Thrombosis and Hemostasis, 2001
- Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsisCritical Care Medicine, 2001
- Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.2001
- High-Dose Antithrombin III in Severe SepsisJama-Journal Of The American Medical Association, 2001
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisThe New England Journal of Medicine, 2001
- Influence of heparin and hirudin on endothelial binding of antithrombin in experimental thrombinemiaCritical Care Medicine, 2000